Richard B. Baxter
CIK: 0002075922
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PTHS
Pelthos Therapeutics Inc.
Director
Discretionary Trading P&L
Holdings
About Baxter Richard B
Baxter Richard B (SEC CIK 0002075922) files insider reports with the SEC as Director of Pelthos Therapeutics Inc. (PTHS).
Signal8 holds 3 ownership filings by Baxter Richard B (1 Form 3, 2 Form 4), filed between Jul 7, 2025 and Apr 1, 2026. Those filings report 3 transactions, the latest on Jul 2, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Baxter Richard B's filings is in DURHAM, NC.
Recent filings by Baxter Richard B
- Jul 2, 2025: Grants or awards of PTHS shares (3 lines, Form 4, code A).
Other insiders filing for Pelthos Therapeutics Inc. (PTHS)
- Greenleaf Peter, Director
- Friedberg Ezra M, Director
- Pauls Matthew, Director
- Davis Todd C, Director
- Francis Knuettel II, CFO, Treas & Secty
- GAY JOHN M., Chief Financial Officer